160 related articles for article (PubMed ID: 6132363)
21. Release of immunoreactive alpha-MSH by synaptosome-enriched fractions of homogenates of hypothalami.
Warberg J; Oliver C; Barnea A; Parker CR; Porter JC
Brain Res; 1979 Oct; 175(2):247-57. PubMed ID: 487155
[TBL] [Abstract][Full Text] [Related]
22. gamma-Aminobutyric acid inhibits the release of alpha-melanocyte-stimulating hormone from rat hypothalamic slices.
Delbende C; Jégou S; Tranchand-Bunel D; Blasquez C; Vaudry H
Brain Res; 1989 Sep; 497(1):86-93. PubMed ID: 2551453
[TBL] [Abstract][Full Text] [Related]
23. Regulation of alpha-melanocyte-stimulating hormone release from superfused slices of rat hypothalamus by serotonin and the interaction of serotonin with the dopaminergic system inhibiting peptide release.
Tiligada E; Wilson JF
Brain Res; 1989 Dec; 503(2):225-8. PubMed ID: 2557964
[TBL] [Abstract][Full Text] [Related]
24. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
Pugsley TA; Lippmann W
Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
[TBL] [Abstract][Full Text] [Related]
25. Systemically administered prolyl-leucyl-glycinamide fails to alter dopaminergic neuronal activity in the rat brain.
Alper RH; Moore KE
J Pharm Pharmacol; 1981 Apr; 33(4):259-61. PubMed ID: 6115917
[No Abstract] [Full Text] [Related]
26. Central-type benzodiazepines inhibit release of alpha-melanocyte-stimulating hormone from the rat hypothalamus.
Blasquez C; Jégou S; Tranchand Bunel D; Delbende C; Braquet P; Vaudry H
Neuroscience; 1991; 42(2):509-16. PubMed ID: 1680228
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
[TBL] [Abstract][Full Text] [Related]
28. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
[TBL] [Abstract][Full Text] [Related]
29. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
Verma V; Mann A; Costain W; Pontoriero G; Castellano JM; Skoblenick K; Gupta SK; Pristupa Z; Niznik HB; Johnson RL; Nair VD; Mishra RK
J Pharmacol Exp Ther; 2005 Dec; 315(3):1228-36. PubMed ID: 16126839
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of morphine analgesia by alpha-MSH, MIF-I, melatonin and naloxone in the rat.
Datta PC; Sandman CA; Hoehler FK
Peptides; 1982; 3(3):433-7. PubMed ID: 6126866
[TBL] [Abstract][Full Text] [Related]
31. Release of alpha-MSH from a synaptosome-enriched fraction prepared from rat hypothalamic tissue.
Warberg J; Oliver C; Eskay RL; Parker CR; Barnea A; Porter JC
Front Horm Res; 1977; 4():167-9. PubMed ID: 614134
[No Abstract] [Full Text] [Related]
32. Dopaminergic inhibition of alpha-melanocyte-stimulating hormone release from superfused slices of the rat hypothalamus.
Tiligada E; Wilson JF
Brain Res; 1988 Aug; 457(2):379-82. PubMed ID: 2851367
[TBL] [Abstract][Full Text] [Related]
33. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
Kavaliers M; Hirst M
Life Sci; 1986 Nov; 39(19):1729-35. PubMed ID: 2877382
[TBL] [Abstract][Full Text] [Related]
34. Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.
Spirtes MA; Kostrzewa RM; Kastin AJ
Pharmacol Biochem Behav; 1975; 3(6):1011-5. PubMed ID: 4814
[TBL] [Abstract][Full Text] [Related]
35. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
36. Modulation of agonist stimulated adenylyl cyclase and GTPase activity by L-pro-L-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes.
Mishra RK; Makman MH; Costain WJ; Nair VD; Johnson RL
Neurosci Lett; 1999 Jul; 269(1):21-4. PubMed ID: 10821635
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.
Kostrzewa RM; Kastin AJ; Sobrian SK
Pharmacol Biochem Behav; 1978 Sep; 9(3):375-8. PubMed ID: 30981
[TBL] [Abstract][Full Text] [Related]
38. Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
Chiu S; Wong YW; Wan YP; Chiu P; Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):739-42. PubMed ID: 6141616
[TBL] [Abstract][Full Text] [Related]
39. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
Johnson RL; Rajakumar G; Mishra RK
J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
[TBL] [Abstract][Full Text] [Related]
40. [Control of pituitary secretion of melanotropin in an anuran amphibian by thyrotropin releasing factor (TRH). Study in vitro].
Vaudry H; Trochard MC; Leboulenger F; Vaillant R
C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):961-5. PubMed ID: 16704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
